Oxytocin in MRI-HIFU

• Status: Unknown status
• Trial end date: 2021-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

Capability of oxytocin in improving the efficacy of MRI-HIFU is studied. Patients undergoing MRI-HIFU treatment are given oxytocin during treatment and the efficacy of the treatment will be analysed by patient reported symptom questionnaires and imaging data.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Turku University Hospital
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Patients undergoing MRI-HIFU -treatment

• Patients assessed for suitability to MRI-HIFU treatment

• willingness to participate in trial

Exclusion Criteria:

• Known allergy to Syntocinon/oxytocin

• Elevated blood pressure

• ischemic heart disease

• Long QT- interval